Global Airway Management Devices Market Size, Share & Forecast 2026-2033

Overview

The global airway management devices market size was valued at USD 2.7 billion in 2025 and is projected to reach USD 4.6 billion by 2033, growing at a CAGR of 6.3% during the forecast period 2026-2033. The increasing prevalence of respiratory diseases is a major driver, as rising global cases of COPD, asthma, cystic fibrosis, and other pulmonary conditions necessitate more advanced and accessible airway management solutions. Projections from December 2023 estimated that the global COPD patient population could reach nearly 600 million by 2050, a 23% increase from 2020, directly expanding the addressable market for airway management devices. North America led the market with a dominant 47% revenue share in 2025, driven by approximately 16 million COPD patients in the U.S., high surgical procedure volumes, advanced critical care infrastructure, and strong technology adoption.

In September 2024, Baxter International launched its next-generation VEST Advanced Pulmonary Experience (APX) system at the North American Cystic Fibrosis Conference, designed for adults and children with chronic lung conditions, reflecting the trend toward personalized home-based respiratory care. Endotracheal tubes held the largest product type share at 34%, with over 0.80 billion units utilized in 2025. Laryngoscopes are the fastest-growing product segment at 10.2% CAGR, driven by accelerating adoption of video laryngoscopy. In July 2025, Verathon launched GlideScope ClearFit, a cover-based video laryngoscope combining a reusable video baton with single-use covers across six blade options. In January 2025, Ambu launched the SureSight Connect video laryngoscopy solution, fully integrated with Ambu's digital platform, demonstrating the pace of technological innovation reshaping the global airway management devices market.

Drivers

Technological Advancements in Airway Management Devices

Technological advancements are playing a pivotal role in driving the growth of the airway management devices market by improving the safety, accuracy, and efficiency of airway procedures in high-stakes clinical settings including emergency rooms, ICUs, and surgical theaters. Traditional airway management methods often carry limitations including difficult visualization, variability in clinician expertise, and delays in securing the airway. Modern devices enhanced by digital integration, video assistance, and real-time monitoring are addressing these challenges directly, enabling first-pass intubation success, reducing complications, and supporting better clinical decision-making. These innovations are reshaping clinical standards and broadening adoption of advanced airway management solutions across healthcare settings globally.

The growing adoption of single-use and disposable airway management devices represents a transformative trend, driven by heightened focus on infection control, patient safety, and operational efficiency. Single-use video laryngoscopes from Ambu and Verathon, disposable laryngeal mask airways, and single-patient-use endotracheal tubes are increasingly favored by hospitals and emergency medical services seeking to reduce cross-contamination risks while streamlining reprocessing workflows. 

Increasing Prevalence of Respiratory Diseases and Rising Surgical Volumes

The increasing global prevalence of chronic and acute respiratory diseases is a foundational demand driver for the airway management devices market. Diseases including COPD, asthma, cystic fibrosis, obstructive sleep apnea, and acute respiratory infections frequently impair a patient's ability to maintain a clear airway, necessitating medical interventions ranging from endotracheal intubation to non-invasive airway clearance systems. According to projections from December 2023, the global COPD patient population could reach nearly 600 million by 2050 — a 23% increase from 2020 — while the CDC estimated in 2024 that nearly 16 million U.S. adults are already living with COPD. This massive and growing disease burden creates consistent, non-cyclical demand for airway management devices across hospital and home-care settings globally.

The rising volume of surgical procedures globally is equally significant as a market driver, as accurate and secure airway access is essential during virtually all surgeries performed under general anesthesia to ensure proper ventilation and oxygenation. According to the U.S. Census Bureau, the number of Americans aged 100 and older is projected to rise dramatically from 101,000 in 2024 to approximately 422,000 by 2054, with aging populations requiring proportionally more surgical interventions and critical care admissions that drive demand for airway management devices. In June 2023, Teleflex strengthened its portfolio by partnering with Shenzhen Insighters Medical Technology to distribute the Insighters Video Laryngoscope system exclusively in the U.S., supporting enhanced visualization during endotracheal intubation in complex airway scenarios — reflecting the market's response to growing clinical demand for advanced airway tools.

Restraint

High Cost of Advanced Devices and Reimbursement Constraints in Emerging Markets

A significant restraint in the global airway management devices market is the high cost of advanced airway management technologies — particularly video laryngoscope systems — which limits adoption in low-income regions, smaller clinical facilities, and healthcare systems with limited capital budgets. A high-end video laryngoscope system can cost upward of USD 10,000 per unit, which represents a prohibitive investment for rural hospitals, district-level healthcare facilities in developing countries, and ambulatory surgical centers with constrained equipment budgets. This cost barrier is particularly acute in Asia-Pacific developing markets, Latin America, Africa, and parts of Eastern Europe, where the vast majority of healthcare facilities continue to rely on conventional direct laryngoscopes despite their inferior clinical performance in difficult airway scenarios.

Reimbursement challenges compound the cost barrier in many healthcare markets, where government and insurance payers have not yet established adequate reimbursement codes or rates for the use of advanced video laryngoscopy and single-use airway devices, discouraging healthcare provider investment. The shift toward single-use disposable airway devices — while clinically and infection-control justified — also increases per-procedure costs significantly compared to reprocessed reusable devices, creating ongoing cost pressure in budget-constrained healthcare systems. Additionally, environmental concerns about the growing volume of medical device plastic waste generated by disposable airway management products are creating regulatory pressure that may complicate continued adoption of single-use devices in environmentally regulated markets.

Market Trends & Opportunities in Airway Management Devices

Single-Use and Disposable Devices Replacing Reusable Systems Across Clinical Settings

The shift from reusable to single-use disposable airway management devices represents one of the most significant structural trends reshaping the market. Single-use endotracheal tubes, laryngeal mask airways, and video laryngoscopes are increasingly preferred by hospitals and emergency medical services for their infection control benefits — eliminating cross-contamination risks and reprocessing costs while simplifying clinical workflows. The COVID-19 pandemic accelerated this shift by heightening clinical sensitivity to infection transmission pathways, and the momentum has been sustained post-pandemic as clinical protocols, purchasing guidelines, and device manufacturer product portfolios increasingly favor disposable designs. Ambu, Verathon, and Intersurgical are among the manufacturers driving single-use device adoption across video laryngoscopy, supraglottic airways, and respiratory circuits.

Home-Based Respiratory Care Expanding the Airway Management Market Beyond Acute Care

Growing emphasis on managing chronic respiratory conditions in home settings — driven by patient preference, healthcare cost reduction pressures, and improving device technology — is expanding the airway management devices market beyond its traditional hospital and emergency medicine base. Airway clearance therapy systems, home nebulizers, CPAP and BiPAP devices, and portable suction systems are increasingly used by COPD, cystic fibrosis, and sleep apnea patients in home settings. Baxter’s VEST APX home-based airway clearance system. exemplifies how clinical-grade technology is being adapted for reliable home use, creating a growing chronic care management market that complements the traditional acute care device demand base.

AI-Assisted Intubation and Real-Time Guidance Systems

Artificial intelligence is beginning to play a role in airway management through AI-powered image analysis overlaid on video laryngoscope feeds, providing real-time guidance on optimal laryngoscope positioning, glottis identification, and tube placement confirmation. These systems have the potential to significantly improve first-pass intubation success rates in challenging airways — particularly for less experienced clinicians in emergency and pre-hospital settings — while creating objective documentation of intubation attempts for quality assurance purposes.

Segment Analysis

The global airway management devices industry is segmented based on type, patient age, application, end user, and region.

Endotracheal Tubes: Largest Product Type with 34% Share

Endotracheal tubes (ETTs) held the largest product type share at 34% in 2025, driven by their critical and irreplaceable role in airway management during surgeries, emergency care, and intensive care procedures. ETTs provide a definitive, secure airway that enables precise control of ventilation, oxygenation, and anesthesia delivery during surgical procedures, making them the gold standard for airway management in general anesthesia and critical care settings. Over 0.80 billion ETT units were utilized globally in 2025, reflecting the massive scale of surgical and critical care activity that requires these devices. The transition toward single-use ETTs is accelerating to reduce cross-contamination risks and infection rates in hospital settings.

The infraglottic devices segment — encompassing endotracheal tubes and tracheostomy tubes — dominated the broader product type market, reflecting the fundamental and non-substitutable demand for secure lower airway access across the full spectrum of acute care and critical care applications. Tracheostomy tubes represent a growing sub-category driven by increasing long-term ventilator dependency in aging populations and growing ICU admission rates globally. In March 2023, Venture Builder BHV Partners launched Conus Airway, a startup focused on next-generation airway management devices beginning with tracheal and bronchial stenosis treatment in pediatric patients, highlighting innovation activity at the specialized end of the infraglottic devices market.

Video Laryngoscopes: Fastest-Growing Product Segment at 10.2% CAGR

Video laryngoscopes are the fastest-growing product segment in the airway management devices market, projected to grow at a CAGR of 10.2% through 2033, driven by accelerating clinical adoption of enhanced visualization technology that improves intubation success rates and patient safety outcomes, particularly in difficult airway scenarios. Video laryngoscopes provide clinicians with a magnified, real-time video view of the glottis that significantly improves first-pass intubation success rates compared to conventional direct laryngoscopy, reducing the risk of complications including esophageal intubation, hypoxia, and airway trauma that can result from failed or multiple intubation attempts. In July 2025, Verathon launched GlideScope ClearFit, combining a reusable video baton with an industry-leading selection of six single-use covers including Mac, Miller, and Hyperangle options, addressing cost efficiency while maintaining advanced airway visualization. 

Anesthesia Application: Dominant Segment with 36.2% Share

The anesthesia application segment dominated with a 36.25% market share in 2025, driven by its extensive use of airway management devices during the continuously growing volume of surgical procedures performed under general anesthesia globally. Accurate and secure airway access is essential during all general anesthesia cases to ensure proper ventilation, oxygenation, and delivery of inhaled anesthetic agents, making endotracheal tubes, supraglottic airway devices, video laryngoscopes, and related accessories fundamental consumables in every operating room worldwide. Rising surgical volumes driven by aging populations, improving healthcare access in emerging markets, and growing elective procedure demand are creating consistent growth in anesthesia-related airway device consumption.

The emergency medicine application segment is the fastest-growing at a projected 5.95% CAGR through 2033, driven by increasing incidence of trauma cases and respiratory emergencies globally. Emergency airway management in pre-hospital, emergency department, and ICU settings requires rapidly deployable, reliable, and high-performing devices that support immediate life-saving interventions. The growing adoption of advanced airway management protocols in emergency medicine — including video laryngoscopy as a first-line tool rather than a rescue device — is driving above-average growth in emergency medicine airway device demand.

Hospitals: Dominant End-User with 62.2% Market Share

Hospitals accounted for 62.2% of global airway management devices market revenue in 2025, driven by the high concentration of surgical procedures, emergency department activity, and critical care admissions that require airway management interventions. Hospital operating rooms, emergency care departments, and intensive care units collectively represent the highest-volume and highest-value settings for airway management device utilization, with large tertiary hospitals purchasing millions of disposable airway management devices annually. The trend toward disposable devices is particularly evident in hospital settings, where infection control protocols and high patient throughput create strong preference for single-use products that eliminate reprocessing time, cost, and risk.

Home care settings represent the fastest-growing end-user segment as respiratory care increasingly moves from acute hospital settings to chronic disease management in the home, driven by growing patient preference, cost pressure to reduce hospitalizations, and improving technology that makes home airway management more practical. The September 2024 launch of Baxter's VEST APX system designed for home-based airway clearance therapy for cystic fibrosis and chronic lung conditions exemplifies this trend, with technology increasingly bridging the clinical performance gap between hospital-grade devices and practical home-use solutions.

Geographical Penetration

North America Airway Management Devices Market Share: 47% in 2025

North America dominated the global airway management devices market with a commanding 47% revenue share in 2025, driven by the combination of very high respiratory disease prevalence, large and aging population, advanced healthcare infrastructure, high surgical volumes, and strong commercial activity from leading device manufacturers. The CDC estimated in 2024 that nearly 16 million U.S. adults are living with COPD, while the U.S. Census Bureau projects the population of Americans aged 100 and older will grow from 101,000 in 2024 to 422,000 by 2054 — a demographic trend that will proportionally increase surgical interventions and critical care admissions requiring airway management devices over the next three decades.

The United States airway management devices market is driven by rising surgical procedure volumes, strong adoption of advanced video laryngoscopes, and growing home-care respiratory device utilization. The presence of major global airway management device manufacturers including Medtronic, Teleflex, AMBU, Verathon, and Intersurgical in North America ensures continuous innovation and product availability. 

Europe Airway Management Devices Market: Mature Market with Single-Use Adoption

Airway management devices market in Europe is characterized by advanced healthcare systems, high surgical procedure volumes, strong regulatory standards under the EU Medical Device Regulation (MDR), and growing adoption of single-use airway management devices driven by infection control requirements. Germany, France, the UK, Italy, and Spain collectively represent the majority of European demand, with each country's national health service creating substantial and predictable procurement demand for endotracheal tubes, laryngeal mask airways, and video laryngoscopes across hospital networks.

EU MDR compliance requirements — which mandate clinical evidence for all device categories and impose stricter post-market surveillance — are raising the bar for product approval and market access in Europe, creating competitive advantages for established manufacturers with robust clinical evidence portfolios while increasing barriers for smaller or newer market entrants. The growing adoption of video laryngoscopy as standard practice in European anesthesia guidelines is driving significant market growth in advanced airway visualization devices, with companies including Karl Storz, Intersurgical, and Flexicare maintaining strong European market positions alongside global leaders.

Asia-Pacific Airway Management Devices Market: Fastest-Growing Region

Asia-Pacific is the fastest-growing regional market for airway management devices, driven by rapidly expanding healthcare infrastructure, growing surgical volumes, rising respiratory disease prevalence, and increasing healthcare expenditure across China, India, Japan, South Korea, Australia, and Southeast Asia. China airway management devices market is the largest single market within Asia-Pacific, with the country's massive and modernizing hospital network, rapidly growing surgical procedure volumes, and increasing adoption of advanced airway management technologies driving strong demand growth. India's healthcare infrastructure expansion — driven by government Ayushman Bharat program investments and private hospital network growth — is progressively increasing access to surgical and critical care services, expanding the addressable market for airway management devices in what is the world's most populous nation.

Southeast Asian markets including Vietnam, Indonesia, Thailand, and the Philippines are experiencing above-average healthcare infrastructure growth, with increasing numbers of modern hospitals being equipped with ICUs and advanced operating theaters that require comprehensive airway management device portfolios. Japan and South Korea maintain highly advanced healthcare systems with strong demand for premium airway management technologies, including cutting-edge video laryngoscopes and advanced supraglottic airway devices.

Middle East and Africa Airway Management Devices Market

The Middle East and Africa region represents a growing market for airway management devices, driven by significant healthcare infrastructure investment in GCC countries, a large and young population base across Sub-Saharan Africa, and growing access to modern surgical and critical care facilities. GCC countries — particularly Saudi Arabia, UAE, Qatar, and Kuwait — have invested heavily in world-class hospital facilities that require comprehensive airway management device portfolios including advanced video laryngoscopes, single-use ETTs, and supraglottic airway devices. Saudi Arabia's Vision 2030 health sector expansion includes construction of new tertiary hospitals and development of advanced clinical capabilities that drive premium medical device adoption.

Sub-Saharan Africa represents a longer-term growth opportunity as healthcare infrastructure improvements progressively expand access to surgical and critical care services, creating first-time demand for basic and intermediate airway management devices. The high disease burden of respiratory infections, tuberculosis, and other pulmonary conditions across Sub-Saharan Africa creates clinical need for effective airway management that currently outstrips existing healthcare infrastructure capacity. As international and domestic healthcare investment progressively strengthens African hospital networks, the addressable market for airway management devices will expand meaningfully through 2033.

South America Airway Management Devices Market: Brazil-Led Healthcare Expansion

South America's airway management devices market is led by Brazil, which operates the region's most extensive public hospital network through the Sistema Unico de Saude (SUS) and a growing private hospital sector catering to Brazil's large and increasingly insured middle-class population. Brazil's high respiratory disease burden — including elevated asthma and COPD prevalence driven by urban air pollution, smoking rates, and respiratory infection incidence — creates consistent demand for airway management devices in both hospital and home-care settings. Brazil's pharmaceutical and medical device regulatory agency ANVISA maintains oversight over airway management device approvals, with growing alignment with international regulatory standards facilitating market access for global device manufacturers.

Argentina, Colombia, Chile, and Peru represent secondary but growing South American markets for airway management devices, with each country experiencing ongoing healthcare infrastructure development and improving access to surgical and critical care services. The region's private hospital sector is a key driver of premium device adoption, while public healthcare systems focus predominantly on cost-efficient solutions. South America's airway management devices market is expected to grow at a moderate CAGR through 2033, with Brazil maintaining its dominant regional position.

Key Developments

In May 2026, Everis Medical, a medical device company specializing in Otolaryngology, Head & Neck Surgery, and adjacent surgical specialties, announced the acquisition of Hood Laboratories, a privately held medical technology company based in Pembroke, Massachusetts and a leading manufacturer of ENT, airway, and thoracic devices since 1962. The acquisition expands Everis’ specialized product portfolio in Otolaryngology/Head and Neck Surgery (OHNS) and establishes a meaningful entry into airway management.

In May 2026, Verathon, a global medical device company known for its GlideScope® and BFlex™ brands, announced the U.S. launch of SamplePro™, an integrated closed-system specimen collection solution purpose-built for the BFlex™ 2 single-use bronchoscopy platform. SamplePro extends Verathon's leading airway portfolio with a self-sealing sampling solution that protects the collected specimen while safeguarding clinicians and patients. SamplePro addresses that gap with self-sealing valves that maintain a closed system.

In September 2025, Medtronic expanded its airway management device portfolio with new product additions targeting critical care and emergency medicine applications, reinforcing its position in the global airway management devices market.

In July 2025, Verathon announced the launch of GlideScope ClearFit, a cover-based video laryngoscope combining one reusable video baton with six single-use cover options including Mac, Miller, and Hyperangle blade styles for diverse patient types and clinical settings.

In January 2025, Ambu launched the Ambu SureSight Connect video laryngoscopy solution, fully integrated with Ambu aView 2 Advance and Ambu aBox 2 digital systems, designed to streamline intubation in routine and challenging airway procedures in both OR and ICU settings.

In September 2024, Baxter International unveiled the VEST Advanced Pulmonary Experience (APX) system at the North American Cystic Fibrosis Conference, designed for adults and children with chronic lung conditions and retained secretions, enabling home-based airway clearance therapy.